Universal Health price target lowered to $194 from $229 at Cantor Fitzgerald

Cantor Fitzgerald lowered the firm’s price target on Universal Health (UHS) to $194 from $229 and keeps a Neutral rating on the shares. Universal Health Services reported an in-line Q1 and maintained its 2026 outlook, reinforcing that guidance remains achievable but leaving limited near-term upside, the analyst tells investors in a research note. Despite the market sell-off being viewed as overdone, the company’s relative positioning remains less favorable versus peers given stronger upside elsewhere in the provider space and improving payer dynamics, Cantor says.